The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

Drug maker Shanghai Henlius traces its history to 1992, when four ambitious young entrepreneurs formed Fosun Group to seize ...

Researchers at the University of Pennsylvania have turned a deadly fungus into a potent cancer-fighting compound after ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Alembic Pharmaceuticals surged 12% to Rs 1,089.80 after securing USFDA approval for its generic Doxorubicin Hydrochloride ...

Scientists discovered a cancer-fighting compound in mold from ancient tombs, revealing a powerful new drug against leukemia.

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...